Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of ...

Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...

Sotatercept reduced the risk of major morbidity and mortality events by 76% in high-risk patients with PAH compared with placebo. The ZENITH trial was stopped early for efficacy. Adverse events were ...

This story is the first in a series called "Ozempic: Weighing the Risks and Benefits." It was produced in part through a grant from the NIHCM Foundation. When the final results of the SELECT trial ...

(RTTNews) - Amgen (AMGN) announced detailed findings from its Phase 3 VESALIUS-CV clinical trial, revealing that Repatha (evolocumab) significantly reduces major adverse cardiovascular events (MACE) ...